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1. Introduction 
The intestinal tract is commonly involved in ischemia and reperfusion events, resulting from 
illness or surgical procedures that might lead to haemorrhage or shock. Ischemia is 
recognised as a poor blood supply and it is specifically known as intestinal or mesenteric 
ischemia when the bowel is involved. An ischemic insult can develop further into 
inflammation and injury. The mechanisms involved are still subject of  study, but in general, 
an increase in intestinal cell membrane permeability provokes bacterial translocation and 
this in turn results in sepsis and multiple organ failure (MOF). The role of intestinal 
ischemia in septic shock will be discussed in this chapter as well as techniques commonly 
used to monitor gastrointestinal (GI) perfusion. However, most of these techniques depend 
on technical operators thus limiting the diagnosis of intestinal ischemia, which in most 
surgical departments still relies on  clinical symptoms and examination.  
Monitoring metabolic biomarkers has allowed not only the study of metabolic rates of 
tissues and organs, but the rapid detection of life-threatening events. During episodes of low 
blood flow, metabolic needs of the gastrointestinal tissue are not met. Monitoring this 
metabolic imbalance has the potential to provide an early diagnosis and prevent the injury 
from developing further into sepsis. Biosensors have been widely used to study tissue 
metabolism, proteins and nucleic acids with a wide range of applications. Biosensors as a 
diagnosis tool for gastrointestinal pathology will be revised in this chapter. The use of 
biosensors in clinical settings is, however, limited by issues such as biocompatibility, 
sterilisability and immunoreactivity and despite the extensive studies to overcome the 
immune-defensive reactions and toxicity effects due to the direct tissue implantation, other 
techniques have been used as an interface. Microdialysis is an extracting technique widely 
used to sample extracellular fluid of different human tissues. The use of microdialysis for 
the monitoring of digestive organs will be revised and intestinal microdialysis to monitor 
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ischemia further described. Commonly off-line microdialysis pitfalls such as time lag and 
misplacement of samples are exposed as well as the use of recent technologies to overcome 
these issues. The synergetic combination of microdialysis and biosensors is the main reason 
for the position of this technology in the forefront of invasive monitoring. Biocompatibility 
issues of biosensors are extremely simplified when coupled with microdialysis and in turn 
biosensors confer microdialysis with a temporal resolution that it otherwise lacks. Although 
the combination of these techniques is still in research process, it presents the potential of 
close monitoring in clinical settings and home care scenarios for early diagnosis of 
conditions that can lead to sepsis if otherwise missed. 
2. Intestinal ischemia and its role in septic shock 
A poor blood supply to the intestine, also recognised as intestinal or mesenteric ischemia, 
generally leads to inflammation and injury (1) and easily develops into hypoxia (deprivation 
of oxygen supply) causing death of cells and tissue necrosis. This in turn can lead to sepsis 
and end in shock. Conversely, following haemorrhage or shock, the intestinal tract is the 
main organ to experience an ischemic/reperfusion injury. Intestinal cell membrane 
permeability can increase due to mesenteric ischemia (2), provoking bacterial translocation 
and injury of the gut barrier that in turn leads to sepsis and MOF (3-5). Hence, the 
measurement of intestinal permeability has been used as a valuable diagnosis of diseases 
affecting the bowel (6, 7). 
The intestinal barrier protects the gastrointestinal tract, which under normal conditions is 
colonised by the bacterial flora containing enough microorganism, bacteria, and endotoxins 
to kill the host (8). Epithelial cells covering the surface of the gastrointestinal tract forms this 
barrier that prevents the absorption of toxins, antigens, proteases and microorganism across 
the intestinal wall (9). However, bacteria penetrates the intestinal barrier with relative ease 
and it is a common occurrence in healthy patients. This bacterial translocation can lead to 
further damage, worsening the health situation in ill patients (8), hence, it is of utmost 
importance to control this translocation in patients with critical conditions. Some studies 
have focused their efforts on understanding the function and mechanism of the intestinal 
barrier (10, 11), however, these are unclear and the correlation between bacterial 
translocation and intestinal permeability has raised controversies. A correlation between the 
loss of intestinal barrier function and bacterial translocation was found out in rodents, but 
not in humans, where bacterial translocation could not be related to the increase of 
permeability of the atrophied villous (6). Seemingly, no correlation was found after major 
gastrointestinal surgery between failure of the gut barrier function and septic complication 
(11). Hence, some studies have proposed a primary mechanism of translocation in the 
absence of damaged mucosal barrier, where migration of organism across the bowel 
occurred by pinocytosis in epithelial cells (12-14). Nevertheless, other investigations have 
identified alterations in intestinal permeability in critically ill patients, where the loss of 
tight junctions and cells at the villous tip was suggested to be the primary cause of changes 
in intestinal permeability (15, 16). 
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During the first stage of the bacterial translocation process, bacteria adhere onto the 
enterocytes and cross the barrier via transcellular and paracellular mechanisms (12, 17, 18). 
Disrupted epithelial tight junctions (‘leaky gut’) are the cause of bacterial translocation in 
the paracellular route (19, 20). While, intracellular trafficking follows the endocytic uptake 
during the transcellular route (21) (Figure 1). Nevertheless, regardless of the type of 
mechanism, bacterial translocation is triggered by common injuries such as 
ischemia/reperfusion, oxidative stress and bacterial action. Typically, the immune system 
will attack the bacteria once across the barrier. However, if this fails, sepsis or endotoxemia 
occurs, and further damage will develop into MOF (8, 22). In fact, the bowel is the main 
organ involved in MOF and this typically occurs as a consequence of a systemic 
inflammatory response syndrome (SIRS).  
 
Figure 1. Schematic model of disrupted gut epithelial barrier. Ischemia and infection may be the initial 
cause of disruption allowing bacteria and other pathogens to cross the barrier and mix with the luminal 
content. A) Transcellular route occurs by intracellular trafficking; B) Paracellular route occurs due to the 
disruption of tight junctions. 
Insults such as haemorrhage, ischemia/reperfusion, infection or trauma generally lead to an 
inflammatory response and this further develops into shock, if untreated. Toxins induce the 
release of cytokines, leukotrienes and platelets-activating factors (PAF), which play a major 
role in the initiation of shock (23-26). Hence, bacterial and toxin translocation have been 
suggested to be the main cause of all these intestinal dysfunctions (27, 28). The increase of 
membrane permeability has been related to bacterial translocation mechanisms and 
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ischemic process in the intestine. In fact, translocation, vasoconstriction and hypoxic villi are 
common mechanisms occurring in the bowel due to the proximity of this to luminal bacteria 
and toxins (29). Reduction in blood flow is also a cause of initiation of shock, as well as 
activation of endotoxins, which release vasoactive substances and stimulate the formation of 
oxygen free radicals in the tissue (25, 27, 30, 31). The reduction of blood flow means a loss of 
plasma volume and hence a reduction of proteins into the interstitium space, which in turn 
leads to MOF (32-36). The sequence of shock varies with different pathologies (low 
perfusion, hypotension, hemoconcentration, vasocongestion), but the cause of death 
initiated due to the inflammatory response is very similar (37).  
Certain diseases and common surgical procedures can lead to the weakness of blood vessels 
that with the continuous passage of blood can dilate forming an aneurysm. As the aneurysm 
expands, the risk of rupture increases and this can produce severe haemorrhage leading to 
other complications and ultimately to death. The most common abdominal aneurysm occurs 
in the aorta, hence the term abdominal aortic aneurysm (AAA). Ischemic colitis is the most 
common complication after abdominal aortic aneurysm surgery (38, 39) presenting a high 
impact in mortality rates (40-43). Another high risk postoperative complication is the 
leakage of a low rectal anastomosis connection, or the site where the two transacted bowel 
segments are joined again, closing the bowel lumen (44). Anastomosis leaks can easily 
develop into sepsis increasing the mortality toll. Although other variables contribute to the 
risk of anastomosis leakage, ischemia is the main factor related to anastomosis leak (45-47). 
During cardiac surgery with cardiopulmonary bypass (CPB), there is a high risk of patients 
developing intestinal mucosal ischemia. This may further lead to a disturbed mucosal 
integrity and increased intestinal permeability due to imbalance between splanchnic oxygen 
supply and demand which may contribute to systemic inflammation (48). Hence, an early 
diagnosis and the evaluation of an adequate splanchnic perfusion are crucial to improve 
outcome rates following surgical procedures such as aneurysm repair, anastomosis 
connections and CPB. 
3. Gastrointestinal perfusion monitoring 
The principal factors in the development of sepsis, systemic inflammatory syndrome and 
MOF are intestinal ischemia and gut barrier failure. These are also the main causes for the 
development of anastomosis leak and present a high rate of recurrence after AAA repair. 
During inadequate blood flow, the metabolic needs of the tissue are not met, leading to 
tissue injury. Consequently, ensuring both perfusion pressure and blood flow to maintain 
the necessary metabolic supply and demand are highly important to avoid diseases (49). It is 
in situations when blood flow has been partially compromised, where an early diagnosis 
could prevent the injury from developing further into organ dysfunction and death. In order 
to monitor these perfusion irregularities, several techniques have been used over the years. 
Human GI perfusion has been monitored by means of tonometry (50-52), laser Doppler 
flowmetry (53, 54), reflectance spectrophotometry (55), near-infrared spectroscopy (56), 
orthogonal polarisation spectral imaging, (57, 58), indocyanine green clearance (59), and 
measurements of plasma D-lactate (60). While the outcome of patients with septic shock can 
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be predicted, these techniques cannot be compared to each other since they measure 
different constituents of GI perfusion (61). Alternatively, intestinal bleeding, which is 
undisputably an indication of organ damage, has been used to diagnose intestinal failure, 
however this fails to quantify the damage. Absorption markers of increasing permeability 
have also been extensively studied to assess gut functions, however, as they are highly 
invasive and require extensive nursing time, they are not appropriate for clinical monitoring 
in the intensive care unit (ICU). Gastrointestinal tonometry, due to its simplicity, is currently 
the most commonly used technique. It provides adequate information of GI perfusion and it 
is highly suitable for use in ICU. The technique consists of a silicone balloon inserted in the 
stomach that automatically infuses and samples gas every 10 minutes. The gas sample is 
analysed automatically using an infrared sensor within the measurement instrument (62, 
63). However, it has several disadvantages as it does not provide a continuous 
measurement, presents long response time and leads to potential systematic errors as the 
gas samples are drawn from the catheter and analysed using an external measurement 
device. Furthermore, this method depends on the technical operator, compromising its 
reproducibility, and the effect of perfusion countercurrents changes on its sensitivity is still 
obscure (64). In addition, improvement of gastrointestinal perfusion has failed to prevent 
mucosal failure and otherwise, increasing the perfusion might have an effect on the 
metabolic rate, modifying the balance between oxygen demand and supply (61). 
Currently, techniques most commonly used in clinical practices for the diagnosis of leaks are 
routine blood tests, colonoscopy, ultrasound and abdominal x-rays such as, CT scans, 
mesenteric angiography and MRIs and as a last resort, an exploratory abdominal surgery. 
Regardless of all advances in clinical technology, the monitoring of gastrointestinal 
perfusion is still limited and in most surgical departments, the diagnosis of intestinal 
ischemia relies on clinical symptoms and examination (65). However, subjectivity, the lack 
of precision and the delayed manifestation of the symptoms account for the unreliability of 
this procedure. 
Research based on microcirculation and secretion during shock has been broadly explored 
at cellular and molecular level, however, there is a lack of information at the organ level 
(66). The mechanism of ischemia before shock and MOF begin, is not only an important area 
of research but one with plenty of room for exploration. Monitoring organ function and 
metabolism could be the ultimate mode of measuring gut perfusion (64), since there are 
evidences of the existence of localised biochemical changes in specific segments of the 
patient’s gut (67). 
Splanchnic hypoperfusion is generally associated with a poor outcome in critically ill 
patients. Moreover, despite presenting a hyperdynamic systemic circulation, the mucosa 
hypoperfusion in gastric, small intestine and colonic tissue commonly develops into sepsis 
(68). Gastrointestinal mucosa has been described as one of the highest metabolically active 
tissues under conditions of sepsis (69, 70) and although no clear association has been found, 
gut flow and metabolic changes appear to be heterogeneous (71-74). During compromised 
mucosal tissue, the reaction mechanism has been proposed as an increase of oxygen 
extraction (75). However, regardless of adequate oxygen delivery, the cells are unable to use 
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oxygen during sepsis (76). During the initiation of intestinal ischemia, whatever the cause of 
injury (bowel strangulation, intestinal perforation or impaired blood flow), a rise in 
intracellular biomarkers occurs due to the increase of intestinal permeability (77). Therefore, 
metabolic levels are presented as useful measurements for the monitoring of intestinal 
ischemia. 
During ischemia, a change from aerobic to anaerobic tissue metabolism occurs, which 
results in a decrease of glucose and pyruvate levels and increased lactate and glycerol levels. 
During anaerobic metabolism, the support of glucose from sphlanchnic circuit is inhibited 
causing pyruvate to accumulate in the tissue. Due to the lack of oxygen, pyruvate cannot be 
incorporated into the citric acid cycle, metabolising pyruvate to lactate. Monitoring the gut 
metabolic markers provides information on the variation from aerobic to anaerobic 
metabolism, the balance between oxygen supply and demand and therefore the ischemic 
degree of that tissue. In order to obtain a more accurate assessment of tissue metabolism, 
determination of lactate/pyruvate or lactate/glucose ratio is preferred compared to lactate 
alone. In addition, during sustained ischemia, a breakdown of the cellular plasma 
membrane occurs resulting in the release of phospholipids into the extracellular fluid, which 
are degraded to free fatty acids and glycerol. Hence, glycerol is another common metabolic 
product monitored during ischemic studies (78). 
4. Biosensors as a diagnosis tool of gastrointestinal pathology 
Over the past few decades, a large number of biosensors (a biological sensing element 
directly interfaced to a signal transducer) have been developed for the detection of various 
metabolites, proteins and nucleic acids with a wide range of applications, such as for 
medical diagnosis of gastrointestinal disorders.  
Currently, the most common minimally invasive method to monitor the perfusion of the 
gastrointestinal tract in clinical settings is gastric tonometry. However, the technique only 
provides discrete measurements. In order to overcome this limitation, an optical fibre sensor 
was developed (79). This is based on the utilisation of a CO2 sensing layer fixed at the end of 
an optical fibre catheter that is connected to an optoelectronic unit. The sensor allows the 
continous monitoring of the rapid changes in the gastric pCO2 and hence provides a better 
understanding of gastrointestinal physiology (Figure 2). 
Monitoring tissue adenosine triphosphate (ATP), in addition to other metabolic products, 
provides a further understanding of the cellular respiration rate. Furthermore, ATP has an 
important function within the immune system as a clotting signal molecule (80) and it is 
thought to regulate serotonin (5-HT) release and hence gastrointestinal motility (81-83). An 
ATP microelectrode biosensor with high long-term stability and selectivity was used to 
study the regulation of mucosal release mechanisms such as 5-HT based on the long-term in 
vitro variations of ATP release from isolated ileum and colon tissues (84).  
Others have developed a microcapillary immunoassay, the Quantum-dot-Linked 
Immunosorbent Assay (QLISA), in order to differentiate between inflammatory bowel  
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Figure 2. Optical probe for continuous monitoring of gastric carbon dioxide. A) Tip of the optical probe 
head; B) Optical probe mounted on a Tonocap catheter for gastric tonometry. Modified with permission 
from Elsevier (79). 
diseases such as ulcerative colitis and Crohn’s disease and irritable bowel syndrome (IBS). 
The fecal levels of the gastrointestinal inflammatory disease’s biomarkers, myeloperoxidase 
and lactoferrin, could be quantified using this biosensor (85). In another study, a filter-
paper-based strip was used to develop a bacterial whole-cell biosensor that allows optical 
on-site detection of a chemical signalling molecule in Gram-negative bacteria, which plays 
an important role in the pathogenesis of several gastrointestinal disorders (86). 
Differentiation of old blood and new blood for the surveillance of rebleeding occurrence 
was possible with an endoscopically implantable wireless biosensor designed to detect 
blood labelled with fluoroscein. This has the potential of immediate, real-time detection of 
upper gastrointestinal bleeding. Furthermore, the wireless signal can be transmitted to 
external computers that relay the data to the patient’s cell phone or to an emergency 
response network allowing an early-warning remote surveillance system. In this way, the 
detection of rebleeding of endoscopically defined sources of GI hemorrhage during periods 
of high risk is possible (87) (Figure 3).  
Studies with biosensors are still commonly performed in animal models or rely on collecting 
patients’ fluids and tissue samples. Implantable biosensors still have problems associated 
with biocompatibility. Damage of the tissue surrounding the biosensor is believed to affect 
the measurement levels. In addition, implanted biosensors suffer the reaction of the tissue 
towards the foreign body, the so-called biofouling. A cascade signal is sent by the immune 
system that triggers the release of platelets and immune proteins as well as the formation of 
new blood vessels, which encapsulate the biosensor and hence impair the sensing layer (88-
90). Therefore, alternative techniques have been explored to monitor gastrointestinal 
biomarkers. 
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Figure 3. Scheme of wireless communication for gastric bleeding. Optical biosensor implanted 
endoscopically in the stomach transmits the signal wirelessly to external computers and to the patient's 
cell phone or other networks. Reprinted with permission from Elsevier (87). 
5. Microdialysis monitoring 
In the early seventies, Ungertstedt and Pycock (91) developed microdialysis, an extraction 
technique to measure interstitial substance in the brain without causing extensive tissue 
damage. The original concept for microdialysis was to mimic a blood capillary (92). 
Microdialysis is based on the passive diffusion of the molecules through a hollow fibre 
membrane (93). A sterile physiological solution (perfusate) is infused by a syringe pump at 
very low flow rates (typically 0.3-2 μl/min). Molecules present in the extracellular fluid 
diffuse to the lumen of the microdialysis (dialysate) and this is sampled through the outlet 
(Figure 4). The membrane cut-off confers selectivity to the technique, limiting the size of 
molecules diffusing through it. In clinical situation, this prevents the passage of virus into 
the dialysate and it eliminates problems associated with instability of metabolites due to 
sample preparation. Since the dialysate is free of proteins, this can be directly injected into 
analytical systems for analysis.  
Since its beginning, microdialysis applications have broadened to the sampling of 
extracellular fluid of different human tissues including ear fluid (94), brain (95, 96), liver 
(97), heart (98), lungs, muscle (99) and bowel (78). The reader is directed to some of the 
reviews on microdialysis found in the literature (92, 100-103). Extensive studies have been 
carried out using microdialysis in the digestive system organs. This section describes some 
of the work published in stomach tissue, liver, pancreas and intestine.  
Gastric microdialysis has been used to continuously monitor gastrin release to determine the 
response to food, acid blockage and acute vagal excitation (104). Microdialysis monitoring of  
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Figure 4. Scheme of a Microdialysis probe. A) Microdialysis membrane is depicted as a tip, which is 
connected via a shaft to the inlet and outlet tubings; B) The semipermeable membrane limits the 
diffusion of large molecules such as red blood cells, large proteins and virus. 
gastric ischemia during temporary celiac artery occlusion in anesthetised rats showed a 
more remarkable response to ischemia in the relative changes of metabolic ratios of 
lactate/pyruvate and lactate/glucose compared to changes in the flow indicator of H2O efflux 
and glycerol (105). Histamine release from enterochromaffin-like (ECL) cells during 
ischemia has been commonly sampled from the stomach submucosa with a single 
microdialysis probe (106-109). However, submucosal microdialysis sampling has been 
suggested to be unrepresentative of histamine levels released from ECL cells, since these are 
located in the mucosa layer, requiring a diffusion of histamine from the mucosa to the 
submucosa and finally to the probe (110). A more accurate sampling of stomach analytes 
was introduced using a multiple probe approach in which the probes were implanted in the 
stomach lumen, mucosa, submucosa and in the blood of a rat (111) (Figure 5). This four-
probe microdialysis sampling was used to directly compare drug absorption between 
gastric ulcerated and healthy tissue in the same animal, where the dialysate was analysed 
using high performance liquid chromatography ultraviolet (HPLC-UV). The study showed 
a higher drug concentration in ulcer tissue, which was a function of ulcer size and thickness 
and probe location within the tissues when compared to healthy tissue (112). The 
reconstructed oesophagus of patients undergoing resection of carcinoma was monitored 
with microdialysis to investigate the risk of postoperative complications caused by ischemia. 
This study showed lactate/glucose ratio to be the most reliable parameter and sets 
microdialysis as a promising method for examination of free jejunal flaps (113). 
Liver metabolism has also been studied using microdialysis sampling. A study in 
anaesthetised rats showed that of the stimulation of hepatic nerves result in glycogenesis via 
α-adrenergic mechanism and eicosanoids mediators (114). Other metabolites typically 
measured in the liver are glucose, lactate, pyruvate and glycerol. Dialysate concentrations of 
these analytes were measured in swine models during and after liver transplantation.  
The samples were collected and analysed at 20 minute intervals during both the donor 
operation and cold preservation, and 7 hours after reperfusion in the recipient (115). 
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Figure 5. Histology images of microdialysis probe implantation (a) in the mucosa right after 
implantation, (b) in the submucosa 2 h post implantation and (c) in the mucosa 12 h post implantation 
(20x magnification). Reprinted with permission from Elsevier (111). 
This led to the monitoring of metabolic changes in liver grafts in a clinical pilot study with 
10 patients (116). Metabolic products were also monitored during ischemia-reperfusion 
injury in the rat liver using microdialysis and commercially available bedside kits (117). This 
study proved that microdialysis is applicable for human liver surgery by continuous 
intraoperative monitoring of intrahepatic metabolism (118). Alternatively, liver slices and 
microsomes have been used to carry out in vitro microdialysis studies of hypoxia (119), 
steroid enzymes activity (120) and drug metabolic processes (121). 
As microdialysis collects only the unbound fraction (the pharmacologically active fraction) 
of the drug, it eliminates the need for unnecessary extensive sample preparation and 
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enzyme degradation processes. This is highly advantageous during pharmacokinetic 
studies, such as the intraperitoneal monitoring of a drug active concentration in freely 
moving rodents (122). Other studies have used microdialysis to investigate the 
pathophysiology of brain activity among irritable bowel syndrome (IBS) patients and brain-
gut interactions. In vivo brain microdialysis monitoring during colorectal distention in rats 
showed that noradrenaline is released in the hippocampus during the distention thus 
suggesting a possible correlation with behavioural changes (123). 
5.1. Intestinal microdialysis  
Microdialysis possesses the advantage of its applicability to other organs in which needle 
puncturing is possible including the stomach and intestines. On the other hand, the 
puncturing performed by the probe implantation, as seen in Figure 5, can inflict an acute 
inflammatory response that may influence the measurement levels and interpretation (124). 
A common solution has been to establish equilibration periods after probe implantation. 
Nevertheless, there is a critical need for smaller microdialysis probes to reduce the damage 
in surrounding tissue and local blood supply. This trauma caused by the implantation of the 
microdialysis probe is one of the main controversial issues when deciding the probe 
placement in gastrointestinal tissue.  
Intraluminal probe placement could be a good approach, because the injury that occurs in 
the bowel causes a bigger damage to the mucosa than to the seromuscular layer, and 
therefore, biomarkers in the lumen rise early during the injury period (125). However, 
intraluminal metabolites measurements have been found to be extremely low and the 
detection is not feasible due to the resting phase of the intestine and to the high volume of 
contents in the lumen (126). A common approach is to place the microdialysis probe in the 
human peritoneal cavity (127-129). The assumption is that due to the high amount of 
intestinal anaerobic products metabolised by the liver, the metabolic markers of an impaired 
circulation are greater in the peritoneum than in blood (77). However, the ischemic 
biomarkers are diluted by non-ischemic markers and by the systemic circulation supplied to 
the peritoneum (78). Sommer et al. compared results from microdialysis probes inserted 
intraperitoneally, intramurally and intraluminally in the bowel of a swine model (126) 
(Figure 6). Insertion of the probe intramurally provides faster detection of metabolic changes 
than intraluminal and peritoneal microdialysis due to the proximity of the probe to the 
damaged tissue and the lack of dilution artifacts (130). However, this is more invasive and 
presents a difficult challenge for the clinician thus requiring intensive training. A recent 
approach has been to evaluate the insertion of the microdialysis probe in pancreatic tissue 
guided by an endoscopic ultrasound device (131), which has the potential to be used in 
other tissues. In addition, the microdialysis probe has a fragile tip, which can be broken 
during the probe implantation. It is increasingly recognised the need for the production of 
less fragile probes and alternative geometries. 
Microdialysis monitoring can be divided into off-line and on-line microdialysis depending 
on the coupling method between the microdialysis outlet and the detection technique.  
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Figure 6. Microdialysis probe placement in the bowel. IL, intraluminal; IM, intramural; EM, extramural; 
IP, intraperitoneal. Reprinted with permission from John Wiley & Sons (126). 
Off-line Microdialysis 
Several studies have used in vivo microdialysis monitoring in animal models to investigate 
splanchnic metabolic disorders by measuring glucose, lactate/pyruvate ratio and glycerol 
both intraluminally (132-134) and in the intraperitoneal space (128). From these studies, 
microdialysis was suggested as a valuable tool for surgeons to detect early signs of 
mesenteric ischemia and the postoperative complications associated with this. In another 
study, microdialysis was used to monitor several episodes of ischemia in the pig intestine. 
The results showed lower dialysate levels of lactate during the second ischemic event 
compared with the first. This suggested that extended periods of ischemia triggered a 
mechanism of protection against hyperpermeability for later ischemic events (135).  
Few have translated this technology to human subjects. Some pilot studies have used 
microdialysis for intraoperative monitoring. Intestinal luminal microdialysis and tonometry 
was used to monitor the rectal mucosa of patients undergoing elective cardiac surgery with 
cardiopulmonary bypass. This combination allowed the monitoring of both circulation and 
metabolism to indicate the adequacy of splanchnic perfusion in the colon (136). Others have 
used blood, urine and interstitial fluid microdialysis samples to investigate the phamacokinetic 
effect of antibiotic concentrations at the sites of infection during AAA open repair surgery 
(137). But, in general, studies in patients are carried out postoperatively. The safety of 
intraperitoneal microdialysis was evaluated to monitor metabolic and inflammatory changes 
in infants after surgery for necrotising enterocolitis (138). Peritoneal microdialysis was used 
postoperatively to assess the anastomosis leak rate in patients undergoing a low rectal 
resection due to cancer. In a medical trial for defunction stoma procedure, where patients were 
randomised, results showed that showed that defunctioning loop stoma decreased the 
probability of anastomosis leak (139). Another study distinguished a higher lactate/pyruvate 
ratio postoperatively in patients presenting anastomosis leakage before evidences of clinical 
symptom compared with those without (140). 
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From these clinical studies, scientists have agreed on the advantages of microdialysis as an 
early indication of intraoperative and postoperative complications compared with 
customary devices for the monitoring of splanchnic circulation. However, most of the 
microdialysis studies presented here used either bulky laboratory techniques such as liquid 
chromatography and electrophoresis or the commercially available bedside kit analyser 
from CMA/Microdialysis (141). Since the detection is off-line, samples are required to be 
collected in vials and manually stored in ice by a trained technician or the ward nurse. This 
time lag and the problem associated with sample misplacement are serious pitfalls of off-
line microdialysis.  
On-line Microdialysis  
In order to have an early diagnosis, a tight monitoring is required. Metabolic events are 
rapid so a continuous monitoring is necessary. In recent years, compact instrumentation and 
microfluidic devices are being coupled online with microdialysis probes to overcome the 
temporal resolution of microdialysis. Lab-on-chip technology, such as microchip 
electrophoresis and liquid chromatography (142, 143) and microfluidic devices that increase 
temporal resolution by creating segmented nanolitres dialysate samples (144) are 
increasingly being investigated. However, the synergetic combination of microdialysis and 
biosensors has put this technology to the forefront of invasive monitoring. Sensitivity and 
biocompatibility of the biosensors increased when coupled to microdialysis and in turn 
biosensors enhance the temporal resolution of microdialysis to the millisecond scale (145, 
146). This technology plays an important role in both point-of-care testing and home care 
(147).  
Some studies placed the biosensors inside the microdialysis tubing (148-150), while others 
use connectors (151-153) or flow injection analysis systems (95, 154, 155). Alternatively, 
miniaturised flow-through biosensors have been fabricated for the connection with 
microdialysis (156). 
An on-line rapid sampling microdialysis biosensor system has been used to monitor 
ischemia at the bowel level. The system couples selectively glucose and lactate 
electrochemical biosensors on-line with the microdialysis probe using a flow injection 
analysis (FIA) system. This allows in vivo monitoring of metabolic substrates changes in the 
colon at a high time resolution, every 30 seconds, without the need for extensive 
manipulation, running by itself during 24 hours up to 5 days (Figure 7). 
Rapid sampling microdialysis was used to monitor rapid changes of glucose and lactate 
levels in patients undergoing an elective colectomy, most typically due to cancer. The 
microdialysis probe was inserted in the seromuscular layer of the colon and sutured to 
ensure fixation and allow the surgeon to proceed with the resection. A stabilisation period 
of 10-15 minutes was allowed before the transection of the main feeding artery, where 
glucose and lactate levels decrease and increase, respectively. These metabolic changes were 
not immediate as expected, but after an average interval of 12 minutes, attributed to the 
colon collateral flow, however, these agreed with the mechanism of blood flow reduction  
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Figure 7. On-line rapid sampling intestinal microdialysis monitoring system. Two probes are 
implanted in the bowel wall, one as a control (off-line) and one as a test (on-line). The system parts are 
placed in a laparoscopy trolley allowing the transport of the system from the lab to clinical settings. 
Reproduced by permission of The Royal Society of Chemistry (157), 
http://pubs.rsc.org/en/Content/ArticleLanding/2011/AY/c1ay05306j 
(158). A preliminary work in animal models was carried out to understand the mechanism 
of ischemia in compromised bowel, such as that after an anastomosis procedure. Here, the 
microdialysis was also tunnelled in the seromuscular layer, but in parallel with the site of 
the anastomosis construction, within a distance of a few millimeters. In this case, glucose 
and lactate changes occurred almost immediately after the feeding artery transection, which 
reveals that the tissue cannot rely on the same collateral flow once it has been compromised 
(by the resection previous to the anastomosis) (157). This has been further illustrated when 
comparing both data, where a therapeutical window is clearly observed in healthy patients 
but not in compromised tissue (159) (Figure 8). 
The system was recognised as a potential candidate for monitoring early diagnosis of 
ischemia after AAA repair surgery. A set of data was obtained during the monitoring of 
aneurysm repair elective surgery patients for up to 2 days in ICU. The probe was 
implanted in the bowel of seven subjects in the mesenteric border of the sigmoid colon just 
at the junction of the mesentery with the colon. Although changes in plasma values were 
observed, dialysate levels for both glucose and lactate were steady. This confirms the fact 
that microdialysis levels are a good indicator of local changes, but it does not reflect 
systemic conditions. The lactate/glucose ratio was observed to be constant for all patients 
for up to 2 days after probe implantation, which strongly indicates the lack of acute 
ischemic events. Some episodes of transient metabolic ischemia were observed due to a 
compromised blood supply, which allows for pattern recognition during further studies 
(160). 
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Figure 8. Microdialysis monitoring of healthy tissue in patients versus compromised anastomotic 
porcine tissue. Percentage of metabolites levels (mean ± sem) monitored during colorectal surgery in 
patients (red & green traces) and in the anastomosis site of porcine bowel wall models (orange & blue 
traces). Glucose traces drop from baseline values, while lactate traces rise. Alignment at the transection 
of main feeding artery (t=0). Reprinted with kind permission from Springer Science & Business Media 
(159). 
6. Conclusion and future trends 
Mesenteric ischemia has been known to increase intestinal cell membrane permeability, 
provoking bacterial translocation and ultimately leading to sepsis and multiple organ 
failure. An adequate splanchnic perfusion and evaluation of intestinal permeability are 
crucial to improve outcome rates following surgical procedures. However, current 
techniques for the diagnosis of leaks are unreliable due to the subjectivity, lack of precision 
and the delayed manifestation of the symptoms. 
Microdialysis has been used to monitor biomarkers in a range of tissues and organs. Clinical 
studies using intestinal microdialysis have agreed on the advantages of the technique as an 
early indication of intraoperative and postoperative complications compared with common 
monitoring of splanchnic circulation. However, off-line detection carries a limitation for the 
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early diagnosis of ischemic insults, since metabolic events are rapid. On-line rapid 
microdialysis technology takes advantage of the synergetic combination of microdialysis 
and biosensors, which plays an important role in both point-of-care testing and home care. 
Microdialysis has recently been evaluated as a tool to assess the metabolic changes during 
liver resection, stomach ischemia and for the diagnosis of novel biomarkers of the pancreas 
that are undetectable in plasma. Preliminary work has been done with microdialysis to 
monitor key metabolites during and after organ transplantation. Although still in early 
stage, this presents the potential of monitoring the organ’s condition during the 
transportation. This will allow not only the determination of the suitability of the organ for 
transplantation, but will also decrease the possibility of occurrence of an ischemic insult by 
perfusing the organ when it reaches a certain predetermined threshold.  
Among some limitations of microdialysis is the trauma caused by the implantation of the 
probe, which causes an inflammatory response and compromises the results of the 
investigation. A common solution has been to establish equilibration periods after probe 
implantation and to develop miniature probes. Since smaller sized probes present high 
back-pressure, a droplet microdialysis probe has been designed to overcome this issue (161). 
Alternatively, flat microdialysis geometries can be envisioned, for those tissues where 
tunnelling of the probe is not necessary. Temporal resolution also limits microdialysis use, 
hence microfluidic and lab-on-chip devices have been investigated to directly connect the 
microdialysis with biosensors (162-164). As the microfabrication technology advances, more 
chips and miniaturised devices will be seen such as micropumps to be implanted in line 
with the microdialysis inlet and wireless detection systems embedded in the probe design, 
reducing in this way bulky instrumentation, otherwise required. One of the paramount 
targets of biomedical research is to be able to create close-loop systems that combine sensing 
devices with drug delivery systems. Microdialysis probes are currently used for drug 
delivery and fluid sampling for diagnosis. Hence, it can be envisioned a device where 
microdialysis is coupled with biosensors for diagnosis and depending on the levels 
recorded, the mechanism switches to a reverse mode delivering the drug required.  
Most microdialysis publications focus on the monitoring of neurochemicals, however, 
general reviews and book chapters are helpful to understand the fundamentals of the 
technique and learn how to handle the probes and perform calibration experiments (165-
167). Originally, microdialysis probes were fabricated from dialysis fibres connected to an 
inlet and outlet tubing. With the expansion of microdialysis, few major trades are handling 
the commercialisation of microdialysis products, producing CE approved sterile probes for 
human use (141) and for in vitro and animal studies (168, 169). 
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